Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients ...

MICB and NOTCH4 were expressed in fibroblasts and endothelial cells, two cell types that play central roles in fibrosis and vasculopathy.

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into effector cells that destroy pathogens.

Multiple Sclerosis (MS) is a lifelong condition that affects the brain and spinal cord, disrupting communication between the brain and the rest of the body. Often misunderstood and sometimes ...

People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the challenges and available support can help you navigate employment and financial stability. Many people ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS). The research combined PET imaging data from 114 ...

Multiple sclerosis isn’t inherited, but having a family member with the disease can increase your chance of having the condition. While genetics influences your risk, environmental factors also ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study, MS treatment ...

From Christina Applegate to Selma Blair to Jack Osbourne, these celebrities have been candid about their journeys with multiple sclerosis Charley Gallay/Getty; Matt Winkelmeyer/Getty; JC Olivera ...

Multiple sclerosis (MS) is a chronic autoimmune disease — one in which the body erroneously attacks itself — that affects the central nervous system. Specifically, MS develops when the immune ...

Many symptoms of MS are the same as those of other conditions. If you are concerned that you may have MS, make an appointment with your primary care provider. They will discuss your concerns and do a ...

This section presents the 2018 AAN Guideline on Disease-Modifying Therapies for Adults with Multiple Sclerosis and the 2018 European Committee for Treatment and Research in Multiple Sclerosis ...